Author(s): 
RA Ducas, MD Seftel, J Ducas, C Seifer
Journal Issue: 
Volume 41: Issue 2: 2011

Format

Abstract
Arsenic trioxide has become the treatment of choice for patients with acute promyelocytic leukaemia. Cardiovascular toxicity is known to occur with this therapy, in particular heart rhythm disorders due to QT interval prolongation. We present a case of ventricular arrhythmia with no QT prolongation in a patient receiving arsenic trioxide therapy.
PDF